Issue 2

NewYork-Presbyterian - Columbia Campus Study on Health Effects of Arsenic in Drinking Water

Inorganic arsenic, a known human carcinogen, is present in varied amounts in drinking water in many parts of the world, including the U.S....Read more

Spotlight on the Asian American Network for Cancer Awareness Research and Training

The Asian American Network for Cancer Awareness Research and Training (AANCART) is the first national cancer awareness project targeting the specific needs of Asian Americans....Read more

Study on the cyclooxygenase-2 (COX-2) inhibitor Celecoxib in Skin Cancer

The Department of Dermatology is embarking on a study to test the hypothesis that the cyclooxygenase-2 (COX-2) inhibitor Celecoxib, administered orally over a period of 24 months, will prevent the development of basal cell carcinomas (BCCs) in patients with the nevoid basal cell carcinoma syndrome (BCNS)....Read more

Outcomes of Tamoxifen Chemoprevention for Breast Cancer in Very High-Risk Women: a Decision Analysis

Study shows benefits in survival when tamoxifen is used as chemopreventive agent....Read more

The Breast Cancer Wars Published

Why do the debates over mammography for women in their forties remain so rancorous?...Read more

Study to test treatments against smoking relapse

Researchers at Columbia University College of Physicians & Surgeons and the New York Psychiatric Institute have launched the first federally-funded study to test whether extended use of smoking cessation drugs can help ex-smokers avoid relapse....Read more

Spotlight on Dr. Martin Lipkin

Dr. Martin Lipkin, Professor of Medicine at Weill Cornell Medical College and Director of Clinical Research at Strang Cancer Prevention Center, has developed numerous research programs in the field of cancer etiology and prevention....Read more